Hong Kong
· Delayed Price · Currency is HKD LifeTech Scientific Statistics
Total Valuation
HKG:1302 has a market cap or net worth of HKD 6.81 billion. The enterprise value is 5.53 billion.
| Market Cap | 6.81B |
| Enterprise Value | 5.53B |
Important Dates
The last earnings date was Friday, March 28, 2025.
| Earnings Date | Mar 28, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
HKG:1302 has 4.63 billion shares outstanding. The number of shares has decreased by -1.16% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 4.63B |
| Shares Change (YoY) | -1.16% |
| Shares Change (QoQ) | -2.57% |
| Owned by Insiders (%) | 15.96% |
| Owned by Institutions (%) | 16.25% |
| Float | 3.89B |
Valuation Ratios
The trailing PE ratio is 27.20 and the forward PE ratio is 15.34.
| PE Ratio | 27.20 |
| Forward PE | 15.34 |
| PS Ratio | 4.91 |
| PB Ratio | 1.84 |
| P/TBV Ratio | 2.31 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 23.38 |
| EV / Sales | 3.99 |
| EV / EBITDA | 19.18 |
| EV / EBIT | 25.04 |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.86, with a Debt / Equity ratio of 0.00.
| Current Ratio | 2.86 |
| Quick Ratio | 2.20 |
| Debt / Equity | 0.00 |
| Debt / EBITDA | 0.02 |
| Debt / FCF | n/a |
| Interest Coverage | 110.25 |
Financial Efficiency
Return on equity (ROE) is 4.96% and return on invested capital (ROIC) is 3.82%.
| Return on Equity (ROE) | 4.96% |
| Return on Assets (ROA) | 2.71% |
| Return on Invested Capital (ROIC) | 3.82% |
| Return on Capital Employed (ROCE) | 5.10% |
| Revenue Per Employee | 996,667 |
| Profits Per Employee | 170,014 |
| Employee Count | 1,392 |
| Asset Turnover | 0.27 |
| Inventory Turnover | 0.63 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -8.70% in the last 52 weeks. The beta is 1.23, so HKG:1302's price volatility has been higher than the market average.
| Beta (5Y) | 1.23 |
| 52-Week Price Change | -8.70% |
| 50-Day Moving Average | 1.54 |
| 200-Day Moving Average | 1.49 |
| Relative Strength Index (RSI) | 48.57 |
| Average Volume (20 Days) | 23,221,921 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, HKG:1302 had revenue of HKD 1.39 billion and earned 236.66 million in profits. Earnings per share was 0.05.
| Revenue | 1.39B |
| Gross Profit | 1.04B |
| Operating Income | 221.75M |
| Pretax Income | 211.76M |
| Net Income | 236.66M |
| EBITDA | 289.32M |
| EBIT | 221.75M |
| Earnings Per Share (EPS) | 0.05 |
Balance Sheet
The company has 1.26 billion in cash and 5.30 million in debt, giving a net cash position of 1.25 billion or 0.27 per share.
| Cash & Cash Equivalents | 1.26B |
| Total Debt | 5.30M |
| Net Cash | 1.25B |
| Net Cash Per Share | 0.27 |
| Equity (Book Value) | 3.70B |
| Book Value Per Share | 0.80 |
| Working Capital | 1.62B |
Cash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 75.28%, with operating and profit margins of 15.98% and 17.06%.
| Gross Margin | 75.28% |
| Operating Margin | 15.98% |
| Pretax Margin | 15.26% |
| Profit Margin | 17.06% |
| EBITDA Margin | 20.85% |
| EBIT Margin | 15.98% |
| FCF Margin | n/a |
Dividends & Yields
HKG:1302 does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 1.16% |
| Shareholder Yield | 1.16% |
| Earnings Yield | 3.48% |
| FCF Yield | n/a |
Stock Splits
The last stock split was on January 12, 2015. It was a forward split with a ratio of 8.
| Last Split Date | Jan 12, 2015 |
| Split Type | Forward |
| Split Ratio | 8 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | n/a |